American College of Clinical Pharmacy
      Search      Cart
         

SCHEDULE

Endocrine and Metabolism PRN Focus Session — Navigating Optimal Medication Strategies and Deprescribing in the Landscape of Intensive Therapeutic Lifestyle Changes for Persons with Type 2 Diabetes

Sunday, October 13, 2024 from 4:00 PM to 5:30 PM MST at Convention Center North Building / North Ballroom 120A

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-24-124-L01-P
Activity Type: A Knowledge-Based Activity

The Endocrine and Metabolism PRN Education Committee presents an educational session focused on integrating lifestyle medicine interventions with medication deprescribing in persons with type 2 diabetes (T2D).  The session serves as a practical, comprehensive guide to the effective integration of lifestyle medicine principles with medication deprescribing for improved and sustained clinical outcomes in persons with T2D. Specific topics will include a (1) review of guideline recommendations of specific dietary and other lifestyle interventions for persons with T2D; (2) review of clinical trial evidence and the use of specific dietary interventions for achievement of glycemic targets and related clinical outcomes; and (3) best practices in deprescribing and/or safe pharmacologic management for persons with T2D implementing intensive or specific dietary interventions. The target audience includes pharmacists, residents, fellows, and students with an interest in enhancing their knowledge of effective and safe pharmacologic management in the setting of intensive therapeutic lifestyle changes (ITLC). The primary purpose of this session is to educate and summarize practical insights and tools to integrate evidence-based lifestyle medicine interventions with medication deprescribing, contributing to more comprehensive and personalized T2D management.

Learning Objectives

1. Discuss the pharmacist’s role in intensive, therapeutic lifestyle changes (ITLC) for type 2 diabetes.

2. Describe guideline recommended ITLC for persons with type 2 diabetes.

3. Summarize available clinical literature of ITLC and intensive lifestyle interventions for achievement of glycemic target and other clinical outcomes in persons with type 2 diabetes.

4. Describe precision ITLC in persons with type 2 diabetes using evidence-based medicine.

5. Review available literature related to best practices in antihyperglycemic deprescribing in the presence of ITLC in persons with type 2 diabetes.

6.Recognize individualized approaches to antihyperglycemic deprescribing with consideration of patient characteristics, preferences, and response to specific ITLC.

Megan E. Wesling, Pharm.D., BCACP, CDCES
Moderator:Megan E. Wesling, Pharm.D., BCACP, CDCES
Chair and Associate Professor in Pharmacotherapy, UNT System College of Pharmacy
Clinical Pharmacist - Ambulatory Care, UNT Health Clinical Practice Group
Fort Worth, Texas
  View Biography

Sweet Liberation: Defeating Diabetes with Lifestyle Interventions

4:00 PM to 4:30 PM
Alaina Van Dyke, Pharm.D., MBA, DipACLM, BCACP
Speaker:Alaina Van Dyke, Pharm.D., MBA, DipACLM, BCACP
Assistant Professor
Texas Tech University School of Pharmacy
Dallas, Texas
  View Biography

Lifestyle Interventions in Type 2 Diabetes: Research Insights and Strategies

4:30 PM to 5:00 PM
Sarah A. Kain, Pharm.D., BCACP, TTS
Speaker:Sarah A. Kain, Pharm.D., BCACP, TTS
Manager and Clinical Pharmacy Specialist, Ambulatory Care
Community Health Network
Indianapolis, Indiana
  View Biography

Precision Care: Deprescribing Antihyperglycemics in the Setting of Intensive, Therapeutic Lifestyle Interventions in Type 2 Diabetes

5:00 PM to 5:30 PM
Nicole P. Albanese, Pharm.D., FCCP, CDCES
Speaker:Nicole P. Albanese, Pharm.D., FCCP, CDCES
Clinical Associate Professor, Assistant Dean for Student Success and Engagement
University at Buffalo, School of Pharmacy
Buffalo, New York
  View Biography